|
Colin R. Mallet, of Vancouver, British Columbia, has served on the Board since December 1995. He has worked in senior executive positions in the pharmaceutical industry in Europe, North America and Southeast Asia. He was President and Chief Executive Officer of Sandoz Canada Inc. (now Novartis A.G.) for seven years and is a past Chair of the Canadian Association of Research-Based Pharmaceutical companies.
He is currently a director of Methylgene Inc. and Migenix Inc., two publicly traded companies and is Chairman of the Corporate Governance Committees of each of these companies. He also serves on the Board of MedGenesis Inc., a privately held company. | 